Arphra/Issuer/DRREDDY.BO

DRREDDY.BO

Dr. Reddy's Laboratories Limited

HealthcareDrug Manufacturers - Specialty & GenericININRCountry macro →

$1,276.40

Jun 02, 2026

AI Brief

Revenue · FY

$335.93B

Net income

$42.85B

FY 2026

EPS · diluted

$51.42

EBITDA

$67.05B

Explain this page

Arphra AIPlain-English read on Dr. Reddy's Laboratories Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1276.40

Change

+7.92%

Period high

$1336.95

Period low

$1182.35

Period start

$1182.752026-02-01

Through 2026-06-02

Peers

No peer list available for DRREDDY.BO.

Sector & industry today

Live

Sectors

Technology
+2.80%
Utilities
+1.81%
Industrials
+1.63%
Healthcare
+1.00%
Energy
+0.92%
Basic Materials
+0.08%
Real Estate
-0.08%
Communication Services
-0.60%
Consumer Cyclical
-0.74%
Financial Services
-1.02%
Consumer Defensive
-1.60%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+1.44%
Broadcasting
+7.65%
Computer Hardware
+5.14%
Software - Infrastructure
+4.30%
Engineering & Construction
+4.05%
Semiconductors
+3.77%
Oil & Gas Drilling
+3.63%
Telecommunications Services
-3.51%
Financial - Capital Markets
+3.47%
Oil & Gas Energy
+3.01%
Beverages - Non-Alcoholic
-2.78%
Medical - Healthcare Information Services
-2.66%

Fair value

Football field →

Weighted blend

$1,116.74

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Total assets

$579.35B

Total debt

$77.34B

Cash & equiv

$15.37B

Operating CF

$53.84B

Free cash flow

$30.51B

Buybacks

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for DRREDDY.BO.

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$335.93B	$46.44B	$42.85B	$51.42	+12.76%